MarketInOut Stock Screener Log In | Sign Up

Oxford Nanopore Technologies Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 16:48
Oxford Nanopore Technologies Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization2,058.65 mln
Float486 mln
Earnings Date03/09/2027

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.13
Reliable

1-Year Forecast

209.82
Limited downside

Relative Strength

94 / 100
Top performer

Debt / Equity

0.10
Very low leverage

Pre-Tax Margin

-49%
Deeply loss-making

Business Description

Oxford Nanopore Technologies, founded in 2005 and based in Oxford, UK, develops and sells cutting-edge DNA and RNA sequencing devices that can analyse genetic data in real time. The company offers a range of products, from small portable readers to larger high-throughput systems, giving researchers flexible options suited to different needs and settings. Its technology supports a wide variety of scientific work, including human genetics, cancer studies, disease outbreak tracking, and environmental monitoring. The company operates across the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

Key Fundamentals

EPS-13.00
ROE-25.82
RPS0.24
ROIC-46.71
ROA-19.23
Interest Cover-57.62
EBITDA, mln-57.40
EV / EBITDA-28.47
EV / EBIT-14.48
Revenue, mln235
EV / Revenue6.95

Quote Details

Last 225.60
Change 10.6 (4.93%)
Open 214.20
Volume 1,590,456
Turnover 358,806,880
Average Volume 3,231,421

Financial Ratios

Pre-Tax Profit Margin-49
Leverage Ratio1.33
Current Ratio3.52
Price / Book4.58
Price / Tangible Book5.39
Debt / Equity0.10
Price / Sales8.21

Financial Strength

Altman Z-Score5.09
Piotroski F-Score 4 / 9
Beneish M-Score-3.13
1-Year Target Price209.82

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.05% 97 / 100   
1 Month 23.62% 99 / 100   
2 Months 102% 99 / 100   
6 Months 109% 99 / 100   
1 Year 67.48% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog